ESR1 and breast cancer: AIB1/Src3 is a coactivator of ERα and is recruited to the CCND1 gene promoter in MCF-7 breast cancer cells treated with E2; AIB1/Src3 recruitment is significantly suppressed by DHT (De Amicis et al. 2019).